MLPH — Molecular Pharmacology (USA) Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Molecular Pharmacology (USA), fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2010 June 30th	2011 June 30th	2012 June 30th	2013 June 30th	2014 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.117	-0.122	-0.179	-0.21	-0.117
Depreciation
Non-Cash Items	0	0	0	0.001	0
Unusual Items
Changes in Working Capital	-0.009	-0.006	0.001	0.002	0.011
Change in Accounts Receivable
Change in Payable / Accrued Expenses
Cash from Operating Activities	-0.125	-0.127	-0.178	-0.206	-0.105
Capital Expenditures	0	0	0	0	0
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0	0	0	0	0
Other Investing Cash Flow
Cash from Investing Activities	0	0	0	0	0
Financing Cash Flow Items	0.204	0.486	0.106	-0.025	0.163
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities	0.204	0.486	0.106	-0.025	0.163
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0	0.001	-0.006	0.004	-0.005